StockData
Moderna, Inc. logo

Moderna, Inc.

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 5/30567% above fair value
$220.83−0.89 (-0.40%)

Close on Nov 2, 2026Market cap $88.16BP/E –Yield –

Moderna Newly initiated Moderna clinical studies in period by Quarter

Newly initiated Moderna clinical studies in period (studies)

QuarterlyAnnual

Moderna Newly initiated Moderna clinical studies in period: 2.00 studies in Q2 2026, unchanged from a year earlier.

Latest, Q2 2026
2.00
Period ended Jun 30, 2026
Change on a year earlier
0.0%
2.00 in Q2 2025
History
34 quarters
Since Q1 2018
Sources
1
ClinicalTrials.gov API v2 (ModernaTX, Inc.)

Where the Q2 2026 figure comes from

Source: ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗

Reported in ClinicalTrials.gov API v2 (ModernaTX, Inc.).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNewly initiated Moderna clinical studies in period (studies)Year on yearSource
Q2 2026Jun 30, 20262.000.0%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q1 2026Mar 31, 20262.00-33.3%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q4 2025Dec 31, 20254.00-20.0%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q3 2025Sep 30, 20254.000.0%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q2 2025Jun 30, 20252.00-33.3%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q1 2025Mar 31, 20253.00-40.0%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q4 2024Dec 31, 20245.000.0%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q3 2024Sep 30, 20244.00-55.6%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q2 2024Jun 30, 20243.00-57.1%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q1 2024Mar 31, 20245.00-44.4%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q4 2023Dec 31, 20235.00-28.6%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q3 2023Sep 30, 20239.00+50.0%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q2 2023Jun 30, 20237.00-36.4%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q1 2023Mar 31, 20239.00+200.0%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q4 2022Dec 31, 20227.00-12.5%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q3 2022Sep 30, 20226.00-14.3%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗

Breakdown

What makes up newly initiated Moderna clinical studies in period

Cite this data

StockData. (2026). Moderna Newly initiated Moderna clinical studies in period, quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/ctgov-new-studies

See every metric in the Moderna KPI table. Data updated Nov 3, 2026.